Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann W Morgan

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Rheumatology (Oxford, England)|July 15, 2011
Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammationLukasz Kozera, Jacqueline Andrews, Ann W Morgan
BMJ Open|November 14, 2025
Early-stage cost-utility analysis of novel diagnostic tests for giant cell arteritis: a modelling study in UK secondary careMiaoqing Yang, Paola Cocco, Sarah L Mackie, et al.
Plos Medicine|December 3, 2020
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort studyMar Pujades-Rodriguez, Ann W Morgan, Richard M Cubbon, et al.
Clinical Endocrinology|December 28, 2020
Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatmentRebecca Sagar, Sarah Mackie, Ann W Morgan, et al.
BMJ Case Reports|October 7, 2019
Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritisCarl Richard Svasti-Salee, Susan P Mollan, Ann W Morgan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 26, 2019
Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in EnglandJianhua Wu, Adam Keeley, Christian Mallen, et al.
Rheumatology (Oxford, England)|December 4, 2023
Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association studyCharikleia Chatzigeorgiou, Jennifer H Barrett, Javier Martin, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysisSarah Louise Mackie, Elizabeth M A Hensor, Ann W Morgan, et al.
The Journal of Rheumatology|July 3, 2017
Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis RegisterSarah Twigg, Elizabeth M A Hensor, Paul Emery, et al.
Oxford Medical Case Reports|June 13, 2015
Curry-assisted diagnosis in the rheumatology clinicSarah L Donaldson, Maura Cobine-Davies, Ann W Morgan, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|July 15, 2011
Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammationLukasz Kozera, Jacqueline Andrews, Ann W Morgan
BMJ Open|November 14, 2025
Early-stage cost-utility analysis of novel diagnostic tests for giant cell arteritis: a modelling study in UK secondary careMiaoqing Yang, Paola Cocco, Sarah L Mackie, et al.
Plos Medicine|December 3, 2020
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort studyMar Pujades-Rodriguez, Ann W Morgan, Richard M Cubbon, et al.
Clinical Endocrinology|December 28, 2020
Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatmentRebecca Sagar, Sarah Mackie, Ann W Morgan, et al.
BMJ Case Reports|October 7, 2019
Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritisCarl Richard Svasti-Salee, Susan P Mollan, Ann W Morgan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 26, 2019
Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in EnglandJianhua Wu, Adam Keeley, Christian Mallen, et al.
Rheumatology (Oxford, England)|December 4, 2023
Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association studyCharikleia Chatzigeorgiou, Jennifer H Barrett, Javier Martin, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysisSarah Louise Mackie, Elizabeth M A Hensor, Ann W Morgan, et al.
The Journal of Rheumatology|July 3, 2017
Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis RegisterSarah Twigg, Elizabeth M A Hensor, Paul Emery, et al.
Oxford Medical Case Reports|June 13, 2015
Curry-assisted diagnosis in the rheumatology clinicSarah L Donaldson, Maura Cobine-Davies, Ann W Morgan, et al.
Pageof 14